BioNTech Narrows FY2026 Sales Guidance from $1.860B-$2.209B to $1.957B-$2.187B vs $2.020B Est
Benzinga Newsdesk 11 hours ago
NewsGuidance
BioNTech (NASDAQ:BNTX) narrows FY2026 sales outlook from $1.860 billion-$2.209 billion to $1.957 billion-$2.187 billion vs $2.020 billion estimate.
BioNTech (NASDAQ:BNTX) narrows FY2026 sales outlook from $1.860 billion-$2.209 billion to $1.957 billion-$2.187 billion vs $2.020 billion estimate.